Radiotheranostics Market (2022-2035)
Radiotheranostics Market Size, Market Share, Market Volume, AGR%, CAGR%, Market Share, Strategic Drivers, Opportunities, Production, By Radioisotope, By Approach, By Application, By Cancer Type, By Target Biomarker, By Imaging Modality, By Route of Administration, By End Use, By Distribution Channel, By Geographical Regions, Competitive Analysis, Recent Activities, Patient Analysis, Clinical Trails and more.
- Product Id: BMRC 3783
- Pages: 300
- Publish Date: Jun-2026
- Category: Healthcare
Fill Details
Verify Email
Check your inbox for Sample + Methodology
Note: For delivery of sample pages you must have a Domain Specific EmailID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc are not accepted
Segments
By Radioisotope
- Lutetium-177 (Lu-177)
- Actinium-225 (Ac-225)
- Gallium-68 (Ga-68)
- Fluorine-18 (F-18)
- Iodine-131 (I-131)
- Yttrium-90 (Y-90)
- Copper-64 (Cu-64)
- Zirconium-89 (Zr-89)
- Lead-212 (Pb-212)
- Others
By Approach
- Targeted Therapeutic
- Diagnostic Imaging
- Integrated Theranostic Approach
By Application
- Oncology
- Cardiology
- Neurology
- Endocrinology
- Rheumatology
- Others
By Cancer Type
- Prostate Cancer
- Neuroendocrine Tumors (NETs)
- Thyroid Cancer
- Breast Cancer
- Lung Cancer
- Pancreatic Cancer
- Brain Tumors
- Colorectal Cancer
- Ovarian Cancer
- Others
By Target Biomarker
- Prostate-Specific Membrane Antigen (PSMA)
- Somatostatin Receptors (SSTR)
- HER2
- Fibroblast Activation Protein (FAP)
- CXCR4
- EGFR
- Others
By Imaging Modality
- PET/CT
- PET/MRI
- SPECT/CT
- SPECT
- Gamma Scintigraphy
- Others
By Route of Administration
- Intravenous
- Intra-Arterial
- Intratumoral
- Others
By End Use
- Hospitals
- Cancer Centers
- Nuclear Medicine Centers
- Specialty Clinics
- Academic & Research Institutes
- Contract Research Organizations (CROs)
- Radiopharmacies
- Others
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
Top Players includes:
- Novartis AG
- GE HealthCare
- Siemens Healthineers
- Bayer AG
- AstraZeneca
- Eli Lilly and Company
- Pfizer Inc.
- Curium Pharma
- Lantheus Holdings Inc.
- Telix Pharmaceuticals Ltd.
- Bracco Imaging S.p.A.
- Eckert & Ziegler
- ITM Isotope Technologies Munich SE
- Jubilant Radiopharma
- POINT Biopharma Global Inc.
- Fusion Pharmaceuticals Inc.
- RayzeBio Inc.
- Orano Med
- Bristol Myers Squibb
- Johnson & Johnson
- Cardinal Health
- Nordion Inc.
- NTP Radioisotopes SOC Ltd.
- RadioMedix Inc.
- Advanced Accelerator Applications
- Perspective Therapeutics Inc.
- Clarity Pharmaceuticals Ltd.
- Alpha Tau Medical Ltd.
- Y-mAbs Therapeutics Inc.
- Blue Earth Diagnostics Ltd.
- Others
+44-1173181773
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USFIND ASSISTANCE
LONDON OFFICE
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
FOLLOW US
© Copyright 2026-27 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®
